Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-platelet Effects of Colchicine in Healthy Volunteers
NCT02140372Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- May 2014
- Primary completion
- Jan 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in cardiovascular disease (CVD), sponsored by NYU Langone Health. Started May 2014; status: completed.
02
Drugs
colchicine
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02140372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02140372.